CardioIQ
Understanding Your Results

Standard vs Advanced Lipid Panel: Which Do You Actually Need?

"Advanced lipid panel" sounds like the obvious upgrade — more numbers, more insight, more of everything. But more isn't automatically better, and some advanced panels bundle in markers whose evidence is thin. Here's the honest version: what an advanced panel actually adds over a standard one, which additions carry real weight, who genuinely benefits, and how to get the fuller picture from the results you may already have.

What each panel is designed to do

The two tests answer slightly different questions. A standard lipid panel is built to screen the general population and flag frank abnormalities. An advanced panel is built to characterize risk more precisely — especially the risk that a standard panel can under-state. Neither is "wrong"; they're tuned for different jobs.

 
Standard panel
Advanced panel
Core lipids
Total, LDL-C, HDL, triglycerides, non-HDL
All of standard, plus…
ApoB
Not included
Counts atherogenic particles directly
Lp(a)
Not included
Detects a common inherited risk factor
Sometimes added
hs-CRP, remnant/particle detail, ApoA1
Best suited to
General screening; ruling out overt problems
Precise risk when "normal" may be incomplete

If you'd like the plain-language tour of what those standard lines mean first, start with how to read your lipid panel. This article is about the step after that: deciding whether the extra numbers are worth adding.

The two additions that actually earn their place

Advanced panels can list a dozen extras, but two carry the strongest evidence and do most of the work. Everything else is secondary.

1. ApoB — the particle count

Standard LDL-C measures the cholesterol your LDL particles carry, not how many particles there are. ApoB counts the atherogenic particles directly, and when the two disagree — discordance — ApoB tracks risk more faithfully. That's why the ESC/EAS guidelines highlight it, particularly when triglycerides are high or metabolic syndrome is present. It's inexpensive, widely available, and for many people it's the single most useful number to add. More in the ApoB guide →

2. Lp(a) — the inherited risk

Lp(a) is a genetically determined particle that raises cardiovascular risk independently of the rest of your panel, and it's essentially never in a standard test. Because it's largely fixed for life, it only needs measuring once — which makes it one of the highest-value single tests you can do. If you have an unexplained family history of early heart disease, this is often the missing piece. More in the Lp(a) guide →

An honest caveat

Not every "advanced" marker is equally proven. The evidence behind ApoB and Lp(a) is strong and guideline-backed; some other add-ons have weaker support and can add cost without adding clarity. A good advanced panel isn't the one with the most boxes ticked — it's the one that measures what changes the decision. More numbers you don't know how to read isn't more insight.

Who actually benefits from going advanced

An advanced panel isn't for everyone, and it isn't urgent for everyone. It's most worth it if one or more of these fits you:

If none of these apply and your standard panel is genuinely clean, there's no need to rush — though a one-time Lp(a) is reasonable for almost anyone, precisely because you only ever do it once.

You already have a standard panel — now what?

You usually don't need to start over. In most cases the practical upgrade is small: ask your doctor to add an ApoB to your next blood draw, add a one-time Lp(a) if you've never had it, and then read the whole set — old and new — against optimal targets rather than population ranges. That last step, the interpretation, is where the numbers turn into a decision.

How to actually get it done

The loop
Add ApoB + one-time Lp(a) Interpret vs optimal Discuss with your physician Retest
Medical disclaimer. This article is educational and reflects general cardiovascular science — it is not a diagnosis, not medical advice, and not a substitute for care from your own physician. Which tests are appropriate for you is a clinical decision that depends on your full history and should be made with your treating physician. This article does not recommend any specific test for any individual.

Have a standard panel — want the advanced read?

CardioIQ takes the lab results you already have — plus ApoB and Lp(a) if you've added them — and interprets the full set against longevity-optimal targets, in a physician-grade report built by a lipidologist.

See how a CardioIQ report works Not sure what your numbers mean yet? Normal cholesterol, still at risk? →
TG
Tea Gamezardashvili, MD, PhD, MHA, FACC Preventive Cardiologist & Lipidologist
President, Georgian Atherosclerosis Association · National Coordinator, EAS Lipid Clinic Network (Georgia) · Academic Director, CMEA. CardioIQ is built by a lipidologist, not a tech company.

References

  1. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal. 2020;41(1):111–188. doi:10.1093/eurheartj/ehz455
  2. Mach F, Koskinas KC, Roeters van Lennep JE, et al. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal. 2025;46(42):4359–4378. doi:10.1093/eurheartj/ehaf190
  3. Kronenberg F, Mora S, Stroes ESG, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: an EAS consensus statement. European Heart Journal. 2022.